| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |